Publications by authors named "Jin Runyan"

Claim this Profile
U
US Food and Drug Administration Approval Summary: Nivolumab Plus Platinum-Doublet Chemotherapy for the Neoadjuvant Treatment of Patients With Resectable Non-Small-Cell Lung Cancer.
Oladimeji Akinboro, Nicole Drezner, Anup Amatya, Jin Runyan, Jeanne Fourie-Zirkelbach

J Clin Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Capmatinib and Tepotinib for the Treatment of Metastatic NSCLC Harboring MET Exon 14 Skipping Mutations or Alterations.
Luckson N Mathieu, Erin Larkins, Oladimeji Akinboro, Pourab Roy, Anup K Amatya, Runyan Jin

Clin Cancer Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Calaspargase Pegol-mknl For Treatment of Acute Lymphoblastic Leukemia in Children and Young Adults.
Ruo-Jing Li, Runyan Jin, Chao Liu, Xianhua Cao, Michael L Manning

Clin Cancer Res· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Accelerated Approval of Pembrolizumab for Second-Line Treatment of Metastatic Melanoma.
Meredith K Chuk, Jennie T Chang, Marc R Theoret, Emmanuel Sampene, Kun He, Runyan Jin

Clin Cancer Res· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval: Uridine Triacetate for the Treatment of Patients Following Fluorouracil or Capecitabine Overdose or Exhibiting Early-Onset Severe Toxicities Following Administration of These Drugs.
Gwynn Ison, Julia A Beaver, W David McGuinn, Todd R Palmby, Jeannette Dinin, Runyan Jin

Clin Cancer Res· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 1 Study of ABT-751 in Combination With CAPIRI (Capecitabine and Irinotecan) and Bevacizumab in Patients With Advanced Colorectal Cancer.
Michelle A Rudek, Arvind Dasari, Daniel Laheru, Ping He, Runyan Jin

J Clin Pharmacol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Ramucirumab for Gastric Cancer.
Sandra J Casak, Ibilola Fashoyin-Aje, Steven J Lemery, Lillian Zhang, Runyan Jin

Clin Cancer Res· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: "Understanding triphasic HCV decline during treatment in the era of IL28B polymorphisms and direct acting antiviral agents via mathematical modeling".
Charles D Howell, Runyan Jin, Thomas C Dowling

J Hepatol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimum ribavirin exposure overcomes racial disparity in efficacy of peginterferon and ribavirin treatment for hepatitis C genotype 1.
Runyan Jin, Ling Cai, Ming Tan, John G McHutchison, Thomas C Dowling

Am J Gastroenterol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics and pharmacodynamics of ribavirin in patients with chronic hepatitis C genotype 1 infection.
Runyan Jin, Michael J Fossler, John G McHutchison, Charles D Howell, Thomas C Dowling

AAPS J· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation and implementation of a liquid chromatography/tandem mass spectrometry assay to quantitate dimethyl benzoylphenylurea (BPU) and its five metabolites in human plasma and urine for clinical pharmacology studies.
Michelle A Rudek, Ming Zhao, Ping He, Yelena Zabelina, Runyan Jin

J Chromatogr B Analyt Technol Biomed Life Sci· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclosporine and bromocriptine-induced suppressions of CYP3A1/2 and CYP2C11 are not mediated by prolactin.
Shirley K Lu, Shellie M Callahan, Runyan Jin, Lane J Brunner

Eur J Pharmacol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Silencing of RNA helicase II/Gualpha inhibits mammalian ribosomal RNA production.
Dale Henning, Rolando B So, Runyan Jin, Lester F Lau, Benigno C Valdez

J Biol Chem· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Down-regulation of RNA helicase II/Gu results in the depletion of 18 and 28 S rRNAs in Xenopus oocyte.
Hushan Yang, Juhua Zhou, Robert L Ochs, Dale Henning, Runyan Jin

J Biol Chem· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis